• About us
  • Privacy Policy
  • Contact us
Neo Science Hub
ADVERTISEMENT
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
Neo Science Hub
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Loyal’s Drug Extends Lifespan of Larger Breeds

Neo Science Hub by Neo Science Hub
3 years ago
in Healthcare & Medicine, Science News
0
Dog Health LOY-001 Drug | Neosciencehub

Dog Health LOY-001 Drug | Neosciencehub

New Hope for Canines

Loyal for Dogs’ innovative drug, LOY-001, shows potential to extend the lifespans of larger breeds, a significant breakthrough in canine aging research acknowledged by the FDA, aiming for a healthier, longer life for our beloved pets, reports Rashmi Kumari.

Great news for dog enthusiasts! Imagine extending your furry friend’s lifespan beyond the typical 1-16 years. Exciting possibilities await for those who cherish their canine companions.

Veterinary biotech company Loyal for Dogs is making significant strides in the development of a drug, known as LOY-001, which holds the potential to prolong the lifespan of larger canine breeds. The drug, currently in the pre-clinical stage, is specifically targeted at dogs aged 7 and older, weighing at least 40 pounds.

The United States Food and Drug Administration (FDA) has recognized the initial data’s sufficiency, indicating a “reasonable expectation of effectiveness” for LOY-001. This marks a notable achievement for Loyal, with CEO Celine Halioua expressing pride in what is believed to be the FDA’s first formal acceptance for developing and approving a drug to extend canine lifespan.

LOY-001 functions by inhibiting insulin growth factor-1 (IGF-1), a growth-related hormone linked to aging in various animals. Loyal is concurrently developing two other versions, LOY-002 and LOY-003, both available in a daily pill form. These drugs also target IGF-1 and are designed for different categories of older dogs.

Larger dog breeds, characterized by elevated IGF-1 levels, typically have shorter lifespans compared to their smaller counterparts. Loyal’s observational study, involving over 450 large dogs, revealed a correlation between lower insulin levels and reduced frailty, leading to an improved quality of life. This significant finding, combined with extensive technical information, prompted the FDA to acknowledge LOY-001’s potential to extend dog life spans.

FDA Approval and Future Goals

With a validated proof of concept, Loyal aims to secure conditional approval for LOY-001 by 2026. This would enable expedited market availability while ongoing clinical trials collect additional evidence. Celine Halioua and her team aspire to extend dog lifespans by at least a year through these trials.

As discussions on longevity drugs for animals gain momentum, experts emphasize the importance of ensuring that an extended lifespan corresponds to a high quality of life for pets. Kate Creevy, Chief Veterinary Officer of the Dog Aging Project, underscores the need for a focus on improving health and well-being in any attempts to extend canine lifespans.

Beyond the realm of veterinary medicine, pathways explored in longevity drugs for dogs may have implications for human health. While no longevity drug has received FDA approval to date, the pursuit of such developments raises ethical considerations and sparks debates about the responsibilities owed to pets.

Loyal is actively recruiting over a thousand senior dogs for clinical trials scheduled to commence in 2024/2025. Simultaneously, the Dog Aging Project is working on a potential life-extending drug for canines called Rapamycin, which targets the mTOR molecule and shows anti-aging effects in various organisms.

This breakthrough in canine longevity research signifies a promising step toward enhancing the well-being and lifespan of our loyal companions. As science and veterinary medicine continue to advance, the prospect of extending the lives of our furry friends opens new avenues for exploration and ethical considerations.

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Tumblr (Opens in new window) Tumblr
  • Share on Telegram (Opens in new window) Telegram
  • Email a link to a friend (Opens in new window) Email
Tags: Aging StudiesBiotech BreakthroughCanineLifespanfeaturedPet HealthsciencenewsVeterinary Science
Neo Science Hub

Neo Science Hub

NEO SCIENCE HUB is envisaged as a Web Portal and E-Magazine to provide digital access to the cutting edge and advanced technology, hosted across the globe in all the disciplines of Science

Other Posts

Bar chart of decreasing bars beside a line-art antibiotic icon

When the Last Antibiotic Fails: ICMR Finds 91 Per Cent Carbapenem Resistance in a Common Hospital Pathogen

November 21, 2026
0
Map of India's east coast with a stylised cyclone and its forecast track

Akvan Turns North and Drops a Category: IMD Now Expects a Severe Cyclone Between Narsapur and Puri, While Andhra’s Own Forecasters Expect Less

November 21, 2026
0

Antalya’s Last Forty-Eight Hours: Two Contradictory Paragraphs on Fossil Fuels, and India’s Line on the Carbon Budget

Disarm, Don’t Kill: CCMB Scientists Find Two Compounds That Stop a Deadly Fungus Turning Invasive

Eighty Per Cent of the Cost: Andhra Pradesh Raises the Stakes in India’s Chip-Subsidy Contest

Before the First Breath: UNEP and WHO Say Hormone-Disrupting Chemicals Reach Us in the Womb

The Morning Eye Closes: NASA Will Switch Off Terra After 27 Years of Watching the Planet

A Status Lost: Measles Is Endemic Again in the United States, Mexico and Bolivia

Next Post
Dr.Labani Ray Geothermal Modelling | Neosciencehub

Dr.Labani Ray- A Beacon of Brilliance

Please login to join discussion

Subscribe to Us

Latest Articles

Cross-section of a human eye with the optic nerve head highlighted

FDA Orders Eye-Risk Warnings on All GLP-1 Drugs, From Ozempic to Mounjaro

November 12, 2026
11

Delhi’s Diwali, Measured: Firecrackers Drove 71% of Fine Particles, Lead Hit 20 Times the Limit, and the Worst Readings Went Missing

Global Carbon Budget 2026: The World’s Fossil Emissions Dip, India’s Rise 4.4%, and the 1.5 °C Budget Is Nearly Spent

A New Kind of Blood Thinner: FDA Approves Asundexian to Prevent Repeat Strokes

Andhra Pradesh Opens the Door to Small Nuclear Reactors, Robots and Giga-Scale AI Data Centres — With the Details Still to Come

“Off the Charts”: WMO Tells COP31 That 2026 Is Among the Hottest Years on Record as a Record El Niño Builds

  • Advertise
  • Terms and Conditions
  • Privacy Policy
  • Refund Policy
  • Contact
For Feedback : Email Us

Copyrights © 2025 Neo Science Hub

No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Copyrights © 2025 Neo Science Hub

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist